title: Effects of nanoparticles on lung physiology in the presence or absence of antigen.
abstract: Ambient particulate matter (PM) exacerbates allergic airway diseases. Our previous study showed that diesel exhaust particles, the main constituents in urban PM, enhance airway hyperresponsivness in mice. In addition, health effects of PM with a diameter of less than 100 nm, called nanoparticles, have been reported, and we have also demonstrated that carbon nanoparticles exacerbate antigen-related airway inflammation. The present study investigates the effects of pulmonary exposure to two sizes of carbon nanoparticles on lung physiology and lung expression of Muc5ac in the presence or absence of antigen in mice. Nanoparticles alone or ovalbumin (OVA) alone moderately enhanced cholinergic airway reactivity, as assessed by total respiratory system resistance (R) and Newtonian resistance (Rn). In the nanoparticle + OVA groups, all the parameters for lung responsiveness, such as R, compliance, elastance, Rn, tissue damping, and tissue elastance, were worse than those in the vehicle group, the corresponding nanoparticle groups or the OVA group. The lung mRNA level for Muc5ac was significantly higher in the OVA group than in the vehicle group, and further increased in the nanoparticle + OVA groups than in the OVA or the nanoparticle groups. These data suggest that carbon nanoparticles can enhance lung hyperresponsiveness, especially in the presence of antigen. The effects may be mediated, at least partly, through the enhanced lung expression of Muc5ac.
authors.affiliation: Environmental Health Sciences Division, National Institute for Environmental Studies, Tsukuba, Ibaraki, Japan. inoue.kenichirou@nies.go.jp
authors.forename: K
authors.initials: K
authors.lastname: Inoue
authors.forename: H
authors.initials: H
authors.lastname: Takano
authors.forename: R
authors.initials: R
authors.lastname: Yanagisawa
authors.forename: M
authors.initials: M
authors.lastname: Sakurai
authors.forename: S
authors.initials: S
authors.lastname: Abe
authors.forename: S
authors.initials: S
authors.lastname: Yoshino
authors.forename: K
authors.initials: K
authors.lastname: Yamaki
authors.forename: T
authors.initials: T
authors.lastname: Yoshikawa
mesh_terms: D000818:Animals; D000941:Antigens / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D007442:Intubation, Intratracheal; D008168:Lung / Q000294:innervation / Q000502:physiology*; D008297:Male; D016210:Methacholine Chloride; D051379:Mice; D008813:Mice, Inbred ICR; D055271:Mucin 5AC; D009077:Mucins / Q000096:biosynthesis / Q000235:genetics; D018721:Muscarinic Agonists; D053758:Nanoparticles / Q000633:toxicity*; D010047:Ovalbumin / Q000276:immunology / Q000494:pharmacology; D010275:Parasympathetic Nervous System / Q000187:drug effects / Q000502:physiology; D010316:Particle Size; D052638:Particulate Matter / Q000633:toxicity*; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D000941:Antigens; C524679:Muc5ac protein, mouse; D055271:Mucin 5AC; D009077:Mucins; D018721:Muscarinic Agonists; D052638:Particulate Matter; D012333:RNA, Messenger; D016210:Methacholine Chloride; D010047:Ovalbumin